THROMBOCYTOPENIA, IMMUNE

Clinical trials for THROMBOCYTOPENIA, IMMUNE explained in plain language.

Never miss a new study

Get alerted when new THROMBOCYTOPENIA, IMMUNE trials appear

Sign up with your email to follow new studies for THROMBOCYTOPENIA, IMMUNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Terminated 1

New hope for kids with rare bleeding disorder

Disease control Not yet recruiting

This study aims to see if a new drug called QL0911 is safe and effective at raising platelet counts in children with a chronic bleeding disorder called immune thrombocytopenia (ITP). It will involve 60 children aged 1 to 18 who have not responded well to previous treatments. The …

Matched conditions: THROMBOCYTOPENIA, IMMUNE

Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

THROMBOCYTOPENIA, IMMUNE

Get alerted when new THROMBOCYTOPENIA, IMMUNE trials appear

New hope for kids with rare bleeding disorder